Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
Source:http://linkedlifedata.com/resource/pubmed/id/15890569
Int. J. Radiat. Oncol. Biol. Phys.
2005
Jun
1
62
2
309-17
